These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33541278)

  • 1. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
    Chandra NL; Bolt H; Dan-Nwafor C; Ipadeola O; Ilori E; Namara G; Olayinka AT; Ukponu W; Iniobong A; Amedu M; Akano A; Akabike KO; Okhuarobo U; Fagbemi S; Sampson E; Newitt S; Verlander NQ; Bausch DG; le Polain de Waroux O; Ihekweazu C
    BMC Infect Dis; 2021 Feb; 21(1):143. PubMed ID: 33541278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
    Duvignaud A; Jaspard M; Etafo IC; Gabillard D; Serra B; Abejegah C; le Gal C; Abidoye AT; Doutchi M; Owhin S; Séri B; Vihundira JK; Bérerd-Camara M; Schaeffer J; Danet N; Augier A; Ogbaini-Emovon E; Salam AP; Ahmed LA; Duraffour S; Horby P; Günther S; Adedosu AN; Ayodeji OO; Anglaret X; Malvy D;
    Lancet Glob Health; 2021 Apr; 9(4):e469-e478. PubMed ID: 33740408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone.
    Dahmane A; van Griensven J; Van Herp M; Van den Bergh R; Nzomukunda Y; Prior J; Alders P; Jambai A; Zachariah R
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):126-32. PubMed ID: 24535150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.
    Asogun DA; Adomeh DI; Ehimuan J; Odia I; Hass M; Gabriel M; Olschläger S; Becker-Ziaja B; Folarin O; Phelan E; Ehiane PE; Ifeh VE; Uyigue EA; Oladapo YT; Muoebonam EB; Osunde O; Dongo A; Okokhere PO; Okogbenin SA; Momoh M; Alikah SO; Akhuemokhan OC; Imomeh P; Odike MA; Gire S; Andersen K; Sabeti PC; Happi CT; Akpede GO; Günther S
    PLoS Negl Trop Dis; 2012; 6(9):e1839. PubMed ID: 23029594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria.
    Groger M; Akhideno P; Kleist CJ; Babatunde FO; Edeawe O; Hinzmann J; Akhigbe T; Nwatuzor J; Eifediyi G; Müller J; Hinrichs M; Pahlmann M; Sarpong FN; Wagner C; Thielebein A; Aihonwalan L; Koch T; Riedner M; Ogbaini-Emovon E; Okogbenin S; Günther S; Wicha SG; Ramharter M; Oestereich L; Duraffour S; Erameh C
    Clin Infect Dis; 2023 Feb; 76(3):e841-e848. PubMed ID: 35881530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lassa fever in post-conflict sierra leone.
    Shaffer JG; Grant DS; Schieffelin JS; Boisen ML; Goba A; Hartnett JN; Levy DC; Yenni RE; Moses LM; Fullah M; Momoh M; Fonnie M; Fonnie R; Kanneh L; Koroma VJ; Kargbo K; Ottomassathien D; Muncy IJ; Jones AB; Illick MM; Kulakosky PC; Haislip AM; Bishop CM; Elliot DH; Brown BL; Zhu H; Hastie KM; Andersen KG; Gire SK; Tabrizi S; Tariyal R; Stremlau M; Matschiner A; Sampey DB; Spence JS; Cross RW; Geisbert JB; Folarin OA; Happi CT; Pitts KR; Geske FJ; Geisbert TW; Saphire EO; Robinson JE; Wilson RB; Sabeti PC; Henderson LA; Khan SH; Bausch DG; Branco LM; Garry RF;
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2748. PubMed ID: 24651047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria.
    Buba MI; Dalhat MM; Nguku PM; Waziri N; Mohammad JO; Bomoi IM; Onyiah AP; Onwujei J; Balogun MS; Bashorun AT; Nsubuga P; Nasidi A
    Am J Public Health; 2018 Feb; 108(2):262-264. PubMed ID: 29267063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019-2020.
    Jetoh RW; Malik S; Shobayo B; Taweh F; Yeabah TO; George J; Gbelee B; Teahton J; Jaryan F; Tegli M; Umeokonkwo CD; MaCauley J
    Int J Infect Dis; 2022 Sep; 122():767-774. PubMed ID: 35817283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favourable Outcome of Severe Lassa Fever Following Early Diagnosis and Treatment: A Case Report.
    Onuh JA; Uloko AE
    West Afr J Med; 2021 Apr; 38(4):395-397. PubMed ID: 33904294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005-2008.
    Ehichioya DU; Asogun DA; Ehimuan J; Okokhere PO; Pahlmann M; Olschläger S; Becker-Ziaja B; Günther S; Omilabu SA
    Trop Med Int Health; 2012 Aug; 17(8):1001-4. PubMed ID: 22594713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria.
    Okogbenin S; Okoeguale J; Akpede G; Colubri A; Barnes KG; Mehta S; Eifediyi R; Okogbo F; Eigbefoh J; Momoh M; Rafiu M; Adomeh D; Odia I; Aire C; Atafo R; Okonofua M; Pahlman M; Becker-Ziaja B; Asogun D; Okokhere P; Happi C; Günther S; Sabeti PC; Ogbaini-Emovon E
    Emerg Infect Dis; 2019 Aug; 25(8):1494-500. PubMed ID: 31310586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.
    Okokhere P; Colubri A; Azubike C; Iruolagbe C; Osazuwa O; Tabrizi S; Chin E; Asad S; Ediale E; Rafiu M; Adomeh D; Odia I; Atafo R; Aire C; Okogbenin S; Pahlman M; Becker-Ziaja B; Asogun D; Fradet T; Fry B; Schaffner SF; Happi C; Akpede G; Günther S; Sabeti PC
    Lancet Infect Dis; 2018 Jun; 18(6):684-695. PubMed ID: 29523497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE).
    Duvignaud A; Jaspard M; Etafo IC; Serra B; Abejegah C; Gabillard D; Doutchi M; Alabi JF; Adedokun MA; Akinpelu AO; Oyegunle OO; Etafo J; Dede AO; Onyechi MN; Ireneh MU; Gbenga-Ayeni O; Fadiminiyi KG; Ehigbor PI; Ouattara E; Levy-Marchal C; Karcher S; N'guessan-Koffi L; Ahyi I; Amani E; Diabaté M; Siloué B; Schaeffer J; Augier A; Ogbaini-Emovon E; Salam AP; Horby P; Ahmed LA; Günther S; Adedosu AN; Anglaret X; Ayodeji OO; Malvy D
    Travel Med Infect Dis; 2020; 36():101557. PubMed ID: 31978611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.